Similar articles for PMID: 25784509

Year	Number of Results
1998	2
2000	1
2001	1
2002	1
2003	1
2004	2
2006	2
2009	1
2010	6
2011	4
2012	6
2013	14
2014	16
2015	35
2016	33
2017	46
2018	39
2019	37
2020	32
2021	28
2022	13
2023	9
2024	0

1

Effect of rivaroxaban versus warfarin on health care costs among nonvalvular atrial fibrillation patients: observations from rivaroxaban users and matched warfarin users.

Laliberté F, Cloutier M, Crivera C, Nelson WW, Olson WH, Schein J, Vanderpoel J, Germain G, Lefebvre P. Laliberté F, et al. Adv Ther. 2015 Mar;32(3):216-27. doi: 10.1007/s12325-015-0189-1. Epub 2015 Mar 18. Adv Ther. 2015. PMID: 25784509 Free PMC article.

2

Effects of rivaroxaban versus warfarin on hospitalization days and other health care resource utilization in patients with nonvalvular atrial fibrillation: an observational study from a cohort of matched users.

Laliberté F, Cloutier M, Crivera C, Nelson WW, Olson WH, Schein J, Vanderpoel J, Germain G, Lefebvre P. Laliberté F, et al. Clin Ther. 2015 Mar 1;37(3):554-62. doi: 10.1016/j.clinthera.2015.02.001. Epub 2015 Mar 4. Clin Ther. 2015. PMID: 25749196 Free article.

3

Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?

Laliberté F, Pilon D, Raut MK, Nelson WW, Olson WH, Germain G, Schein JR, Lefebvre P. Laliberté F, et al. Curr Med Res Opin. 2014 Aug;30(8):1521-8. doi: 10.1185/03007995.2014.916159. Epub 2014 May 2. Curr Med Res Opin. 2014. PMID: 24758611

4

Health Care Resource Utilization and Costs Among Newly Diagnosed and Oral Anticoagulant-Naive Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the United States.

Jain R, Fu AC, Lim J, Wang C, Elder J, Sander SD, Tan H. Jain R, et al. J Manag Care Spec Pharm. 2018 Jan;24(1):73-82. doi: 10.18553/jmcp.2018.24.1.73. J Manag Care Spec Pharm. 2018. PMID: 29290177 Free PMC article.

5

Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.

Deitelzweig S, Laliberté F, Crivera C, Germain G, Bookhart BK, Olson WH, Schein J, Lefebvre P. Deitelzweig S, et al. Clin Ther. 2016 Aug;38(8):1803-1816.e3. doi: 10.1016/j.clinthera.2016.07.002. Epub 2016 Aug 2. Clin Ther. 2016. PMID: 27491278

6

Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillation.

Peterson ED, Ashton V, Chen YW, Wu B, Spyropoulos AC. Peterson ED, et al. Am Heart J. 2019 Jun;212:113-119. doi: 10.1016/j.ahj.2019.02.001. Epub 2019 Feb 20. Am Heart J. 2019. PMID: 30981035 Free article.

7

Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting.

Lin J, Trocio J, Gupta K, Mardekian J, Lingohr-Smith M, Menges B, You M, Nadkarni A. Lin J, et al. J Med Econ. 2017 Sep;20(9):952-961. doi: 10.1080/13696998.2017.1341902. Epub 2017 Jun 22. J Med Econ. 2017. PMID: 28604139 Free article.

8

Comparison of Healthcare Resource Utilization and Costs between Rivaroxaban and Warfarin for Nonvalvular Atrial Fibrillation in a Skilled Nursing Facility Setting.

Mahajan D, Wu B, Song J, Milentijevic D, Ashton V, Mittal VS. Mahajan D, et al. Drugs Aging. 2020 Apr;37(4):281-289. doi: 10.1007/s40266-019-00737-x. Drugs Aging. 2020. PMID: 32147804

9

Healthcare costs of NVAF patients treated with rivaroxaban and apixaban in the US.

Milentijevic D, Germain G, Laliberté F, Bookhart BK, MacKnight SD, Tsang J, Lefebvre P. Milentijevic D, et al. J Med Econ. 2020 Nov;23(11):1365-1374. doi: 10.1080/13696998.2020.1821038. Epub 2020 Sep 29. J Med Econ. 2020. PMID: 32897766 Free article.

10

Healthcare utilization and costs for patients initiating Dabigatran or Warfarin.

Reynolds SL, Ghate SR, Sheer R, Gandhi PK, Moretz C, Wang C, Sander S, Costantino ME, Annavarapu S, Andrews G. Reynolds SL, et al. Health Qual Life Outcomes. 2017 Jun 21;15(1):128. doi: 10.1186/s12955-017-0705-x. Health Qual Life Outcomes. 2017. PMID: 28637460 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

291 results

Results by year